Jill Hollway, M.A.

Jill Hollway is the senior coordinator for the OSU RUPP. Her roles include behavior therapist, clinician, data manager, and project coordinator. She is currently pursuing her Ph.D. in the Department of Psychology at OSU.

Education

Ohio Wesleyan University, Delaware, Ohio (1998)
B.A. Psychology magna cum laude, Dean's List, Psi Chi Honorary

Ohio State University, Columbus, OH (2004)
M.A. Applied Behavior Analysis, Special Education

Positions

• 1998-2003: Project Coordinator, Nisonger Center UAP, The Ohio State University, Columbus, OH

• 2002-Present: Coordination and the application completion of both the National Institute of Health's exploratory intervention development research grant R34 mechanism, and the multi-site contract referred to as the Autism Research Units on Pediatric Psychopharmacology (Autsim "RUPP")

• 2004: Preparation and coordination of a Food and Drug Administration (FDA) study audit for the purpose of determining a new drug indication.

• 2004: Behavior Therapist , Nisonger Center UAP, The Ohio State University, Columbus, OH

• 2004: Present Senior Research Coordinator/Behavior Therapist, Nisonger Center UAP, The Ohio State University, Columbus, OH
  

Journal Publications

Research Units on Pediatric Psychopharmacology Autism Network (including J.A. Hollway) Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 2002, 347 (5) 314-321.

Arnold, L.E., Vitiello, B., McDougle, C.J., Scahill, L., Shah, B., Gonzalez, N.M.,
Chuang, S., Davies, M., Hollway, J.A., Aman, M.G., Cronin, P., Koenig K., Kohn, A.E., McMahon, D.J., Tierney, E. (2003), Parent-Defined Target Symptoms Respond to Risperidone in RUPP Autism Study: Customer Approach to Clinical Trials. J. Am. Acad. Child and Adolesc. Psychiatry 42:1443-1450.

Submitted for Publication

Lecavalier, L., Aman, M.G., Scahill, L., McDougle, C.J., Vitiello, B., Tierney, E., McCracken, J.T., Arnold, L.E., Ghuman, J.K., Posey, D.J., Koenig, K., Cronin, P., Lofton, R.L., Martin, A., Hollway, J., Kau, A. S. M., Lee, L. (Submitted). The validity of the Autism Diagnostic Interview--Revised. Journal of Autism and Developmental Disorders.

Research Units on Pediatric Psychopharmacology Autism Network, (including J.A. Hollway). (In press pending final revision). Risperidone treatment of autistic disorder: Longer term benefits and blinded discontinuation after six months. Journal of Developmental and Behavioral Pediatrics.

Arnold, L.E., M.D., DiSilvestro, R.A., Hollway, J.A., Hernan Bozzolo, B.A., Amy Cook, B.A., Dawn R. Bozzolo, B.A., Lindsay Crowl, Yaser Ramadan, M.D., Craig Williams, M.D. (submitted for publication) Zinc in Attention Deficit Hyperactivity Disorder: Correlation with parent/teacher-rated inattention. Journal of Child and Adolescent Psychopharmacology.

Letters

Arnold, L. E., Bozzolo, H., Hollway, J.A., Bozzolo, D.R., Ramadan, Y., Crowl, L. Williams, C. Carnitine may improve arithmetic performance in Attention Deficit Hyperactivity Disorder (ADHD). (Submitted for publication).

Abstracts

McDougle, C.J., Aman, M.G., McCracken, J.T., Scahill, L., Tierney, E., Vitiello, B., (including J.A. Hollway) and theRUPP Autism Network (2001). A double-blind placebo-controlled trial of risperidone in autistic disorder. American College of Neuropsychopharmacology (Scientific Abstract). Nashville, TN: Vanderbilt Medical Center and American College of Neuropsychopharmacology.

McDougle, C. J., Aman, M.G., McCracken, J.T., Scahill , L., Tierney, E., Vitiello, B., (including J.A. Hollway) and the RUPP Autism Network. A double-blind placebo-controlled trial of risperidone in autistic disorder. The American College of Neuropsychopharmacology 40th Annual Meeting. Entry 172, scientific abstract.

Research Units on Pediatric Psychopharmacology Autism Network (including J.A.
Hollway) (May, 2002). A placebo-controlled study of risperidone in the treatment of children with autistic disorder. Pediatric Research, 51, 458A.

Poster Sessions

McDougle, C.J., Aman, M., McCracken, J.T., Scahill, L., Tierney, E., Vitiello, B., (including J.A. Hollway) & RUPP Autism Network (2001). A double-blind placebo-controlled trial of risperidone in autistic disorder. Presented at the American College of Neuropsychopharmacology, San Juan, Puerto Rico.

McDougle, C.J., Aman, M.G., McCracken, J.T., Scahill, L., Tierney, E., Vitiello, B.,
(including J.A. Hollway) and the RUPP Autism Network (December, 2002). Risperidone treatment of autistic disorder: Longer-term benefits and blinded discontinuation after six months. American College of Neuro-Psychopharmacology, San Juan, Puerto Rico.

Paper Presentations

McDougle, C.J., Aman, M., McCracken, J.T., Scahill, L., Tierney, E., Vitiello, B., (including J. A. Hollway) & RUPP Autism Network (2001). A double-blind placebo-controlled trial of risperidone in autistic disorder. Presented at the American College of Neuropsychopharmacology, San Juan, Puerto Rico.

McDougle, C.J., Aman, M.G., McCracken, J.T., Scahill, L., Tierney, E., Vitiello, B.,
(including J.A. Hollway) and the RUPP Autism Network (December, 2002). Risperidone treatment of autistic disorder: Longer-term benefits and blinded discontinuation after six months. American College of Neuro-Psychopharmacology, San Juan, Puerto Rico.

Hollway, J.A., (2003, October). The Effects of risperidone in children with Autism.
Autism Society of Ohio Bi-Annual State Conference, Perrysburg, OH.

Hollway, J.A., Gardner, R., Hessler, T. L., (March 2004) Fostering Behavioral Momentum in the Home: Parents as Behavioral Change Agents and the Implications for Families of Children with Autism. Behavior Analysis Association of Michigan Conference - Eastern Michigan University.

Hollway, J.A., Gardner, R., Hessler, T. L., (May 2004) Fostering Behavioral Momentum in the Home: Parents as Behavioral Change Agents and the Implications for Families of
Children with Autism. The Association for Behavior Analysis Conference Boston.